Malignant lymphoma is actually a systemic disease, and immune system function is closely related, is different from other entities lymphoid malignant tumor, but also distinct from blood cancer. It includes a disease Hodgkin’s lymphoma and non-Hodgkin’s lymphoma a group of diseases, clinical manifestations because of pathological type, stage and location of different and complex in nature.

     Treatment current use of combined therapy, which is different tumor types and different pathological subtype, different biologic behavior, in different phases and development trends, the different body organs of the state and important function in a planned and rational application all existing treatment, with a view to minimizing the protection of the body and maximize kill tumor cells to improve the cure rate, improve the quality of life purposes. The current commonly used in the treatment of malignant lymphoma means including surgical resection, radiotherapy (radiotherapy), the chemical treatment (chemotherapy), Chinese medicine, biological response modifier (BRM). Surgery combined radiotherapy and chemotherapy for malignant lymphoma or a higher cure rate of remission rate, Chinese medicine is to enhance and restore immune function, the ability to mobilize resistance, reducing the body of radiotherapy and chemotherapy-induced adverse reactions play a synergistic Attenuated role.

     1, in colorectal surgery for patients with malignant lymphoma, mainly used for surgery or biopsy for the trip pathological staging of laparotomy. As for the original, in the brain, spinal cord, eyes, salivary glands, thyroid, lung, liver, spleen and other places, the end of malignant lymphoma often first make surgical resection, supplemented by radiotherapy and / or chemotherapy. The primary kidney, bladder, testicular, ovarian, uterine, skin, breast and other places, the malignant lymphoma to early surgical resection and postoperative supplemented by chemotherapy and / or radiotherapy.

     2, radiotherapy

     (1) Hodgkin’s disease: effects of radiotherapy and more lymph sarcoma cell sarcoma mesh better irradiation method “mantle” or inverted “Y” - type radiation field application more. General four weeks in about 4000 cGy to organizations, treatment to protect vital organs, skin reaction light, there will be the bone marrow suppression.

     (2) non-Hodgkin’s lymphoma (lymph sarcoma and reticular cell sarcoma): non-Hodgkin’s lymphoma is sensitive to radiotherapy, but the high recurrence rate. So only low grade of the group I, II and moderate pathological stage I malignant group can be used alone or radiotherapy only involved expanding wild wild. Non-Hodgkin’s lymphoma in the primary lesions such as tonsillectomy, the nasopharynx or primary cells in the bone of the organization, local radiotherapy can be more satisfied with the long-term remission.

     3, chemical treatment

     4, immune therapy for malignant lymphoma, immunotherapy can be used as adjuvant therapy methods.

     5, autologous bone marrow transplantation following the 50-year-old patients can tolerate high-dose radiotherapy and chemotherapy for the treatment, combining different gene or autologous bone marrow transplantation, is expected to make a longer remission period and the disease-free survival.